by Dr. William Makis, Global Research:
Papers Reviewed
- Sep. 22, 2023 – Blix et al. – Norwegian study of 20,000 women
- Sep. 2023 – Thabet et al. – Saudi Study of 500 women ages 18-45
- Sep. 2023 – Jensen et al. – Danish study of 13,600 women ages 16-65
- Aug. 2023 – Trogstad et al. – Norwegian study of 3972 women ages 18-30
- June 2023 – Paik et al. – South Korean study of abnormal uterine bleeding
- June 2023 – Yoon et al. – South Korean Survey of 2849 people ages 18-49
- June 2023 – Wali et al. – Saudi Study of 300 women ages 15-50
- Aug. 2022 – Isaakov et al – Israeli study of 7476 vaccinated women
TRUTH LIVES on at https://sgtreport.tv/
Sep. 22, 2023 – Unexpected vaginal bleeding and COVID-19 vaccination in non-menstruating women
- Norwegian study of women who self-reported experiencing unexpected vaginal bleeding after COVID-19 vaccination
- Results are based on self-reported data from questionnaires issued in August and September 2021.
- 7725 postmenopausal women (non-menstruating) – 3.3% had bleeding
- 7148 perimenopausal women (non-menstruating) – 14.1% had bleeding
- 7052 premenopausal women (non-menstruating) – 13.1% had bleeding
- 50% of these happened within 28 days of COVID-19 Vaccination
- Moderna had 32% increased risk compared to Pfizer
- In postmenopausal women, the risk of unexpected vaginal bleeding in the 4 weeks after COVID-19 vaccination was increased two- to threefold
- risk of unexpected vaginal bleeding after vaccination was increased three- to fivefold in both non-menstruating peri- and premenopausal women
- European Medicines Agency recently decided that the product information of the mRNA vaccines (i.e., Spikevax and Comirnaty) should be updated to include heavy menstrual bleeding as a potential side effect
- postmenopausal bleeding following COVID-19 vaccination can be a symptom of endometrial carcinoma and precancerous lesions and is considered an important medical event
- Authors: “Increased risk after both Pfizer and Moderna suggest a mechanism related to the spike protein and not to other vaccine components. Pathways related to local changes in the endometrium, possibly resulting from a spike related immune response or related to the endometrial expression of ACE2 receptors may be involved”
- Experts are not entirely sure why changes in menstruation occur, but some believe the vaccine causes some of the body’s tissue to become inflamed, causing changes to the lining of the uterus and hormone levels throughout the body.
Sep. 2023 – Thabet et al. – Saudi Study of 500 women ages 18-45
- Online self-administered survey of 500 Saudi women ages 18-45
- 44% reported menstrual disturbance
- “found a significant relationship between the duration of flow, menstrual blood loss, and severity of dysmenorrhea before and after receiving the first, second, and third doses of Covid-19 vaccine”
- “present study concluded that women who receive the Covid-19 vaccine may experience menstrual abnormalities, such as a significant difference in cycle length, flow duration, menstrual blood loss, and dysmenorrhea severity before and after receiving the first, second, and third doses of the vaccine.”
Sep. 2023 – Jensen et al. – Danish study of 13,600 women ages 16-65
- Danish study of 13,648 women ages 16-65 who completed surveys
- 30% of all menstruating women reported menstrual changes after COVID-19 vaccination
- “several potential risk factors including stress, vaccine concerns, severe COVID-19 infection, and immediate vaccine symptoms were associated with these reports.”
Aug. 2023 – Trogstad et al. – Norwegian study of women ages 18-30
- Norwegian survey of 3972 women ages 18-30 years old
- 38.8% reported menstrual disturbance after 1st vaccine dose
- heavy bleeding in 13.6% after 1st dose and 15.3% after 2nd dose
- prolonged bleeding in 12.5% after 1st dose and 14.3% after 2nd dose
- Authors: “We found increased risk of menstrual disturbances after vaccination, particularly for heavier bleeding than usual, prolonged bleeding, shorter interval between menstruations, and stronger period pain.”
June 2023 – Paik et al. – South Korean study of abnormal uterine bleeding
- “Korean Specialized Committee for the compensation of loss after COVID-19 vaccination has decided to include abnormal uterine bleeding (AUB) as a “suspected related symptom” after COVID-19 vaccination on August 16, 2021, for all vaccine types, including those manufactured by Oxford-AstraZeneca, Moderna, Pfizer-BioNTech, and J&J.”
- “This decision has enabled those who developed AUB after vaccination for COVID-19 to claim compensation from the committee and receive support.”
- “The scientific basis for this decision was the analysis by the COVID-19 Vaccine Safety Committee of the National Academy of Medicine of Korea. After a comprehensive analysis of domestic and international data on adverse reactions reported after COVID-19 vaccination, the committee has announced the discovery of a statistically significant association between AUB and COVID-19 vaccination, which is sufficient evidence to establish a causal relationship.”
June 2023 – Yoon et al. – South Korean Survey ages 18-49
- South Korean researchers conducted a survey of 2849 people ages 18-49
- “A notable finding was that over 15% of female participants reported menstrual disorders and unexpected vaginal bleeding after mRNA vaccination”
June 2023 – Wali et al. – Saudi Study of 300 women ages 15-50
- Saudi researchers studied 300 women ages 15-50 years old
- 44% reported a change in the length and amount of the menstrual cycle
- 29% reported worsened premenstrual syndrome (PMS)
- 11% reported decreased libido
- 10% noticed a decrease in milk production
- 4% lost their pregnancy
Aug. 2022 – Isaakov et al – Israeli study of 7476 vaccinated women
- Israeli researchers conducted a nationwide questionnaire survey: 7904 women
- 49.3% of women had changes in menstrual patterns after COVID-19 vaccination
- 80.6% of them had “excessive bleeding”
- 61.1% of cases it occurred between vaccination and the ensuing menstrual period
- Conclusion: “long-term consequences of the BNT162b2 vaccine on uterine bleeding warrant further investigation.”
Serious Adverse Event Cases of Vaginal Bleeding:
VAERS ID 1904168 – 7 year old from Georgia had 1st Pfizer
